Bimiralisib
Bimiralisib Uses, Dosage, Side Effects, Food Interaction and all others data.
Bimiralisib is under investigation in clinical trial NCT02723877 (PQR309 and Eribulin in Metastatic HER2 Negative and Triple-negative Breast Cancer (PIQHASSO)).
| Trade Name | Bimiralisib |
| Generic | Bimiralisib |
| Bimiralisib Other Names | Bimiralisib |
| Type | |
| Formula | C17H20F3N7O2 |
| Weight | Average: 411.389 Monoisotopic: 411.163057401 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Bimiralisib
